Companies / Financials
RJF
Raymond James Financial
Investment Banking & Brokerage
Investment Banking & BrokerageAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health71
Growth56
Profitability61
Cash generationn/a
Balance sheetn/a
Dilution control96
Key ratios and five-year financials
Latest quarter revenue YoY (2026-06-30)13.5%Revenue growth (FY)6.6%Revenue CAGR (3y)12.1%Gross margin—Operating margin—Net margin13.4%Free cash flow margin14.1%R&D / revenue—Stock comp / revenue1.6%Net debt / operating cash flow—Current ratio—Diluted share count change-2.7%
| Fiscal year ending | FY 2021-09 | FY 2022-09 | FY 2023-09 | FY 2024-09 | FY 2025-09 |
|---|---|---|---|---|---|
| Revenue | $9.9B | $11.3B | $13.0B | $14.9B | $15.9B |
| Net income | $1.4B | $1.5B | $1.7B | $2.1B | $2.1B |
| Operating cash flow | $6.6B | $72M | -$3.5B | $2.2B | $2.4B |
| Capital expenditure | $74M | $91M | $173M | $205M | $188M |
| Free cash flow | $6.6B | -$19M | -$3.7B | $1.9B | $2.2B |
| Stock-based comp | $132M | $192M | $237M | $254M | $254M |
| Buybacks | $128M | — | — | — | — |
| Dividends | $218M | — | — | — | — |
| Cash | $7.2B | $6.2B | $9.3B | $11.0B | $11.4B |
| Equity | $8.2B | $9.5B | $10.2B | $11.7B | $12.5B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.